Astria Therapeutics, Inc. - Common Stock (ATXS) — AI analysis & news
Astria Therapeutics, Inc. - Common Stock (ATXS) stock: 12 recent news items, slightly positive aggregate sentiment, AI analysis and market context on…
Current sentiment read
Across the last 12 indexed ATXS stories, aggregate finance-aware sentiment is slightly positive (+0.28 on a -1 to +1 scale).
Latest ATXS news
- Roth/MKM initiates Atrium Therapeutics stock with buy rating By Investing.com - Investing.com UK · Investing.com UK
- Guggenheim initiates Kazia Therapeutics stock with buy rating By Investing.com - Investing.com India · Investing.com India
- Why is Kazia Therapeutics stock rallying today? - Investing.com · Investing.com
- Leerink initiates Kazia Therapeutics stock with $30 target - Investing.com · Investing.com
- Kazia Therapeutics stock falls on $40M public offering - Investing.com · Investing.com
- Why is Kazia Therapeutics stock rallying today? By Investing.com - Investing.com UK · Investing.com UK
- Leerink initiates Kazia Therapeutics stock with $30 target By Investing.com - Investing.com UK · Investing.com UK
- Bambusa Therapeutics Files for IPO to Fund Eczema Drug Trials · Bloomberg
- Why is Atrium Therapeutics stock surging today? - Investing.com · Investing.com
- Why is Atrium Therapeutics stock surging today? By Investing.com - Investing.com India · Investing.com India
- Atrium Therapeutics raises $50 million in private placement By Investing.com - Investing.com UK · Investing.com UK
- Caspian Therapeutics and Kura Oncology to host investor call By Investing.com - Investing.com UK · Investing.com UK
FAQ
What is the current sentiment for ATXS stock?
Aggregate finance-aware sentiment across the last 12 indexed ATXS news stories is slightly positive (+0.28 on a -1 to +1 scale).